Product Information
CETAPHIL DAILY FACIAL LOT is a brand product labeled by Galderma Laboratories, L.P., priced at $0.1100 per ML under NDC 00299392804. Its NADAC has been published 94 times since Dec 18, 2024.
Strength
3; 10 g/100mL; g/100mL
Manufacturer
Galderma Laboratories, L.P.NDC
00299392804
Classification
Brand
Dosage Form
LOTION
Route
TOPICAL
Effective Date
5/20/2026
Active Ingredients
AVOBENZONE; OCTOCRYLENEApproval Type
OTC MONOGRAPH DRUG
FDA Application
M020On Market Since
4/1/2000
Price Statistics
The NADAC for CETAPHIL DAILY FACIAL LOT has been published 94 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1100 per ML |
|---|---|
| All-time high | $0.1101 (Sep 10, 2025) |
| All-time low | $0.1089 (Jan 22, 2025) |
| 52-week high | $0.1100 |
| 52-week low | $0.1100 |
| Median price | $0.1100 |
| Average price | $0.1099 |
| Largest weekly change | -0.9% (Jan 22, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the octocrylene, avobenzone market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Galderma Laboratories, L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
octocrylene, avobenzone market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CETAPHIL DAILY FACIAL LOT?
The current National Average Drug Acquisition Cost (NADAC) for CETAPHIL DAILY FACIAL LOT, manufactured by Galderma Laboratories, L.P., is $0.1100 per ML (NDC 00299392804), effective Sep 30, 2026.
How has the price of CETAPHIL DAILY FACIAL LOT changed over time?
Over the history we have for it, the NADAC for CETAPHIL DAILY FACIAL LOT has held within roughly two percent of its current level. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for CETAPHIL DAILY FACIAL LOT?
Since Dec 18, 2024, the NADAC for CETAPHIL DAILY FACIAL LOT has ranged from a low of $0.1089 (Jan 22, 2025) to a high of $0.1101 (Sep 10, 2025), with a median of $0.1100 per ML.
Are there cheaper alternatives to CETAPHIL DAILY FACIAL LOT?
No other NADAC-published product currently shares the active ingredient and strength of CETAPHIL DAILY FACIAL LOT in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CETAPHIL DAILY FACIAL LOT?
CETAPHIL DAILY FACIAL LOT (NDC 00299392804) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.